Early research (Phase 1)UnknownNCT03310008
What this trial is testing
Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases
Who this might be right for
Colon Cancer Liver Metastasis
Celyad Oncology SA 36